Name: GSM2212076 - Doxorubicin4 vs Control4, 4 week post treatment, reverse labelling
Creator: Saket Lab
License: https://www.ncbi.nlm.nih.gov/geo/info/disclaimer.html

GSM2212076 - Doxorubicin4 vs Control4, 4 week post treatment, reverse labelling | seqout